{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T10:12:26Z","timestamp":1715335946457},"reference-count":20,"publisher":"Scientific Scholar","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ruralneuropractice.com"],"crossmark-restriction":true},"short-container-title":["JNRP"],"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p>\n<jats:bold>Background<\/jats:bold>\u2003Neoplastic meningitis (NM) is considered as a terminal event with poor prognosis. Its impact in clinical oncology is growing.<\/jats:p>\n<jats:p>\n<jats:bold>Objective<\/jats:bold>\u2003To analyze the clinical outcome of patients with carcinoma breast diagnosed with NM.<\/jats:p>\n<jats:p>\n<jats:bold>Materials and Methods<\/jats:bold>\u2003This study was an observational study in breast cancer patients diagnosed with NM. Patients with typical clinical symptoms and signs with either presence of cerebrospinal fluid (CSF) cytology positive for neoplastic cells or typical radiological features of leptomeningeal involvement in the presence of neurological symptoms or signs were taken as leptomeningeal metastasis (LM) or NM. The estimation of survival was done by Kaplan\u2013Meier method.<\/jats:p>\n<jats:p>\n<jats:bold>Results<\/jats:bold>\u2003Out of 1,200 patients diagnosed with carcinoma breast during the study period, 15 developed NM. The median age of study population was 51 (range: 44\u201355) years. Most common presentations were headache (47%), vomiting (47%), diplopia (20%), seizure (20%), and cerebellar signs (7%). Seven (46%) patients were hormone receptor positive, four (30%) were HER2 (Human epidermal growth factor receptor 2) positive and seven (46%) were triple-negative breast cancer. Median time to develop LM from the time of diagnosis of breast cancer was 6 (range: 3\u20138) months. Nine patients (90%) had features of NM in CSF cytology. Thirteen patients received palliative whole brain radiotherapy (20 Gy in five fractions). Nine out of 12 patients received single-agent Capecitabine as first-line chemotherapy after palliative radiation therapy (RT). Intrathecal methotrexate was given for seven patients. The median overall survival was 3 (range: 0.5\u20134) months.<\/jats:p>\n<jats:p>\n<jats:bold>Conclusion<\/jats:bold>\u2003LM is a very aggressive metastatic disease with poor outcome. There is an unmet need for proper guidelines and an overwhelming necessity for a better focus on research for new modalities of disease in this scenario.<\/jats:p>","DOI":"10.1055\/s-0041-1741505","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T23:51:10Z","timestamp":1641945070000},"page":"108-113","update-policy":"http:\/\/dx.doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Outcome of Neoplastic Meningitis Associated with Breast Cancer"],"prefix":"10.25259","volume":"13","author":[{"given":"Anju Anna","family":"Abraham","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Regional Cancer Center, Thiruvananthapuram, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anoop","family":"T.M","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Regional Cancer Center, Thiruvananthapuram, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rona Joseph","family":"P.","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Regional Cancer Center, Thiruvananthapuram, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Vasudevan","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Regional Cancer Center, Thiruvananthapuram, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavya S.","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Regional Cancer Center, Thiruvananthapuram, Kerala, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"issue":"12","key":"10.1055\/s-0041-1741505\/ref-1","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1002\/cncr.23088","article-title":"Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis","volume":"110","author":"Altundag","year":"2007","journal-title":"Cancer"},{"issue":"11","key":"10.1055\/s-0041-1741505\/ref-2","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/bjc.2012.163","article-title":"Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden","volume":"106","author":"Frisk","year":"2012","journal-title":"Br J Cancer"},{"issue":"42","key":"10.1055\/s-0041-1741505\/ref-3","doi-asserted-by":"crossref","first-page":"73312","DOI":"10.18632\/oncotarget.20272","article-title":"Leptomeningeal disease: current diagnostic and therapeutic strategies","volume":"8","author":"Nayar","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1055\/s-0041-1741505\/ref-4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/CCO.0b013e32833de986","article-title":"Leptomeningeal metastasis","volume":"22","author":"Chamberlain","year":"2010","journal-title":"Curr Opin Oncol"},{"issue":"2","key":"10.1055\/s-0041-1741505\/ref-5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11060-011-0664-8","article-title":"Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment","volume":"106","author":"Kim","year":"2012","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1055\/s-0041-1741505\/ref-6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0030-1255220","article-title":"Leptomeningeal metastasis","volume":"30","author":"Chamberlain","year":"2010","journal-title":"Semin Neurol"},{"issue":"1","key":"10.1055\/s-0041-1741505\/ref-7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ana.410380111","article-title":"Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis","volume":"38","author":"Freilich","year":"1995","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1055\/s-0041-1741505\/ref-8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1212\/WNL.50.2.438","article-title":"111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases","volume":"50","author":"Mason","year":"1998","journal-title":"Neurology"},{"key":"10.1055\/s-0041-1741505\/ref-9","article-title":"Neurological Complications of Cancer. 2nd ed","author":"DeAngelis","year":"2009"},{"key":"10.1055\/s-0041-1741505\/ref-10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ctrv.2015.12.004","article-title":"Therapy of leptomeningeal metastasis in solid tumors","volume":"43","author":"Mack","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"10.1055\/s-0041-1741505\/ref-11","doi-asserted-by":"crossref","first-page":"e000507","DOI":"10.1136\/esmoopen-2019-000507","article-title":"How we treat patients with leptomeningeal metastases","volume":"4","author":"Le Rhun","year":"2019","journal-title":"ESMO Open"},{"issue":"11","key":"10.1055\/s-0041-1741505\/ref-12","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/annonc\/mdq232","article-title":"Survival of breast cancer patients with meningeal carcinomatosis","volume":"21","author":"Gauthier","year":"2010","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1055\/s-0041-1741505\/ref-13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s12032-012-0408-4","article-title":"Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival","volume":"30","author":"Niwi\u0144ska","year":"2013","journal-title":"Med Oncol"},{"issue":"2","key":"10.1055\/s-0041-1741505\/ref-14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11060-013-1175-6","article-title":"Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis","volume":"114","author":"Yust-Katz","year":"2013","journal-title":"J Neurooncol"},{"issue":"11","key":"10.1055\/s-0041-1741505\/ref-15","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1634\/theoncologist.2018-0200","article-title":"Clinicopathological and treatment-associated prognostic factors in patients with breast cancer leptomeningeal metastases in relation to tumor biology","volume":"23","author":"Griguolo","year":"2018","journal-title":"Oncologist"},{"issue":"2","key":"10.1055\/s-0041-1741505\/ref-16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11060-013-1228-x","article-title":"Leptomeningeal metastasis from solid tumors: a single center experience in Chinese patients","volume":"115","author":"Du","year":"2013","journal-title":"J Neurooncol"},{"issue":"2","key":"10.1055\/s-0041-1741505\/ref-17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.14791\/btrt.2018.6.e12","article-title":"A Retrospective analysis of the clinical outcomes of leptomeningeal metastasis in patients with solid tumors","volume":"6","author":"Kim","year":"2018","journal-title":"Brain Tumor Res Treat"},{"key":"10.1055\/s-0041-1741505\/ref-18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejca.2015.12.021","article-title":"Leptomeningeal metastasis: clinical experience of 519 cases","volume":"56","author":"Hyun","year":"2016","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1055\/s-0041-1741505\/ref-19","first-page":"26","article-title":"Management of neoplastic meningitis","volume":"4","author":"Roth","year":"2015","journal-title":"Linchuang Zhongliuxue Zazhi"},{"key":"10.1055\/s-0041-1741505\/ref-20","doi-asserted-by":"crossref","first-page":"102046","DOI":"10.1016\/j.ctrv.2020.102046","article-title":"Intrathecal administration of anti-HER2 treatment for the treatment of meningeal carcinomatosis in breast cancer: a metanalysis with meta-regression","volume":"88","author":"Zagouri","year":"2020","journal-title":"Cancer Treat Rev"}],"container-title":["Journal of Neurosciences in Rural Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ruralneuropractice.com\/clinical-outcome-of-neoplastic-meningitis-associated-with-breast-cancer\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ruralneuropractice.com\/clinical-outcome-of-neoplastic-meningitis-associated-with-breast-cancer\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T04:39:46Z","timestamp":1691210386000},"score":1,"resource":{"primary":{"URL":"https:\/\/ruralneuropractice.com\/clinical-outcome-of-neoplastic-meningitis-associated-with-breast-cancer\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":20,"alternative-id":["10.1055\/s-0041-1741505"],"URL":"https:\/\/doi.org\/10.1055\/s-0041-1741505","relation":{},"ISSN":["0976-3155","0976-3147"],"issn-type":[{"value":"0976-3155","type":"electronic"},{"value":"0976-3147","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"article-number":"108"}}